In its upcoming report, Integral Ad Science (IAS) is predicted by Wall Street analysts to post quarterly earnings of $0.03 per share, reflecting an increase of 400% compared to the same period last year. Revenues are forecasted to be $129.66 million, representing a year-over-year increase of 13.2%.The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timefram ...

In its upcoming report, Landstar System (LSTR) is predicted by Wall Street analysts to post quarterly earnings of $0.92 per share, reflecting a decline of 30.3% compared to the same period last year. Revenues are forecasted to be $1.13 billion, representing a year-over-year decrease of 3.5%.The consensus EPS estimate for the quarter has been revised 2.9% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates d ...

For the quarter ended March 2025, Kemper (KMPR) reported revenue of $1.19 billion, up 5% over the same period last year. EPS came in at $1.65, compared to $1.07 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $1.23 billion, representing a surprise of -3.56%. The company delivered an EPS surprise of +11.49%, with the consensus EPS estimate being $1.48.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectati ...

For the quarter ended March 2025, Nutrien (NTR) reported revenue of $5.1 billion, down 5.4% over the same period last year. EPS came in at $0.11, compared to $0.46 in the year-ago quarter.The reported revenue represents a surprise of -4.18% over the Zacks Consensus Estimate of $5.32 billion. With the consensus EPS estimate being $0.33, the EPS surprise was -66.67%.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectati ...

Core Insights - Pan American Silver reported a revenue of $773.2 million for the quarter ended March 2025, marking a 28.6% increase year-over-year and a surprise of +10.99% over the Zacks Consensus Estimate of $696.62 million [1] - The company's EPS for the quarter was $0.42, significantly up from $0.01 in the same quarter last year, resulting in an EPS surprise of +121.05% compared to the consensus estimate of $0.19 [1] Financial Performance - The stock of Pan American Silver has returned +15.3% over the past month, outperforming the Zacks S&P 500 composite's +10.6% change, and currently holds a Zacks Rank 2 (Buy) [3] - Key production metrics include: - Gold production: 182.2 Koz, slightly below the average estimate of 185.63 Koz [4] - Silver production: 5,003 Koz, exceeding the average estimate of 4,877.26 Koz [4] - La Colorada Operation produced 1.2 Koz of gold, above the average estimate of 0.66 Koz, and 1,389 Koz of silver, slightly above the average estimate of 1,357.67 Koz [4] - Huaron Operation produced 951 Koz of silver, exceeding the average estimate of 888.87 Koz [4] - San Vicente Operation produced 643 Koz of silver, above the average estimate of 629.11 Koz [4] - Dolores Operation produced 349 Koz of silver and 14 Koz of gold, both exceeding their respective average estimates [4] - Shahuindo Operation produced 29.5 Koz of gold, slightly below the average estimate of 30.43 Koz [4] - Timmins Operation produced 28.5 Koz of gold, below the average estimate of 30.31 Koz [4] Pricing Metrics - Average realized prices per ounce were: - Silver: $31.25, slightly below the average estimate of $32.08 [4] - Gold: $2,868, above the average estimate of $2,786.08 [4]

Core Insights - GoodRx Holdings, Inc. reported revenue of $202.97 million for Q1 2025, a year-over-year increase of 2.6% and an EPS of $0.09, compared to $0.08 a year ago [1] - The reported revenue exceeded the Zacks Consensus Estimate of $202.59 million, resulting in a surprise of +0.19% [1] - The company did not deliver an EPS surprise, as the consensus EPS estimate was also $0.09 [1] Performance Metrics - GoodRx's shares returned +4.2% over the past month, while the Zacks S&P 500 composite increased by +10.6% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential outperformance against the broader market in the near term [3] Key Company Metrics - Monthly Active Consumers: 6 million, below the estimated 7 million [4] - Subscription plans: 680 thousand, slightly below the estimated 685 thousand [4] - Revenue from Prescription transactions: $148.92 million, exceeding the estimate of $146.53 million, representing a +2.4% year-over-year change [4] - Revenue from Other sources: $4.38 million, below the estimate of $5.47 million, reflecting a year-over-year decline of -18.5% [4] - Revenue from Pharma manufacturer solutions: $28.65 million, slightly below the estimate of $29.90 million, but showing a +16.9% year-over-year increase [4] - Revenue from Subscription: $21.02 million, above the estimate of $20.79 million, but down -7% year-over-year [4]

Montrose Environmental (MEG) reported $177.83 million in revenue for the quarter ended March 2025, representing a year-over-year increase of 14.5%. EPS of $0.07 for the same period compares to $0.16 a year ago.The reported revenue compares to the Zacks Consensus Estimate of $167.97 million, representing a surprise of +5.87%. The company delivered an EPS surprise of +158.33%, with the consensus EPS estimate being -$0.12.While investors scrutinize revenue and earnings changes year-over-year and how they compa ...

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance. As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately. Sitio Royalties (STR) reported $16 ...

Core Insights - Evertec reported revenue of $228.79 million for the quarter ended March 2025, reflecting an 11.4% increase year-over-year and a surprise of +4.88% over the Zacks Consensus Estimate of $218.15 million [1] - The company's EPS for the quarter was $0.87, up from $0.72 in the same quarter last year, with a surprise of +7.41% compared to the consensus estimate of $0.81 [1] Revenue Breakdown - Payment Services - Puerto Rico & Caribbean generated $55.16 million, exceeding the average estimate of $54.90 million, representing a year-over-year increase of +4% [4] - Payment Services - Latin America reported revenues of $83.78 million, surpassing the average estimate of $81.76 million, with a year-over-year growth of +12.9% [4] - Merchant acquiring, net revenues were $47.65 million, above the average estimate of $45.83 million, showing a +10.6% increase year-over-year [4] - Business solutions revenues reached $65.56 million, exceeding the average estimate of $60.27 million, with a year-over-year change of +12.8% [4] - Corporate and Other segment reported a loss of -$23.35 million, better than the average estimate of -$24.23 million, with a year-over-year change of +0.9% [4] Stock Performance - Over the past month, Evertec's shares have returned +8.2%, while the Zacks S&P 500 composite has changed by +10.6% [3] - The stock currently holds a Zacks Rank 3 (Hold), indicating expected performance in line with the broader market in the near term [3]

For the quarter ended March 2025, LegalZoom (LZ) reported revenue of $183.11 million, up 5.1% over the same period last year. EPS came in at $0.13, compared to $0.09 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $176.51 million, representing a surprise of +3.74%. The company has not delivered EPS surprise, with the consensus EPS estimate being $0.13.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they comp ...